ClinicalTrials.Veeva

Menu

Effect of Fish Oil on Surgery Pain After Knee Replacement Patients: Randomized, Prospective, Double Blind, Placebo Control Trial (EFOPaKR-01)

Clalit Health Services logo

Clalit Health Services

Status

Unknown

Conditions

Rheumatoid Arthritis

Treatments

Dietary Supplement: EPAX 6000 EE 1000mg (0.6 gr DHA+EPA)
Dietary Supplement: Capsules (Placebo)

Study type

Interventional

Funder types

Other

Identifiers

Details and patient eligibility

About

This is a single-center, prospective, randomized, double blind, placebo control study. The aim of this study is to assess the effect of fish oil capsules on pain intensity and postoperative analgesics consumption in patients after knee replacement surgery.

The study population will be adult are referred for knee replacement surgery due to osteoarthritis of the knee.

Full description

Primary outcome:

Post surgical pain level and analgesics use

Secondary outcomes:

  1. Pain levels and analgesic use at six weeks and 3 months after surgery
  2. ω3 incorporation into blood cell membranes(RBC)
  3. Stress and inflammation markers
  4. Rates of postoperative complications

Study Procedure :

Enrolled patient will be randomly divided into a control group and intеrvention group during preoperative clinic visit. Each patient will receive total 150 capsules (5 capsules per day) accordingly to randomized group.

Patients in treatment group will receive Fish Oil capsules. Patients in control group will receive placebo capsules.

Enrollment

60 estimated patients

Sex

All

Ages

50 to 80 years old

Volunteers

No Healthy Volunteers

Inclusion and exclusion criteria

Inclusion Criteria:

Patients are referred for knee replacement surgery due to osteoarthritis of the knee

  • Exclusion Criteria:

    • Use of steroids, NSAIDs two weeks before surgery, antidepression drugs, antiepileptic drugs, coumadin
    • Diabetic neuropathy
    • Herpes-zoster/ post-herpetic neuralgia
    • n-3 supplements use

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Triple Blind

60 participants in 2 patient groups, including a placebo group

Fish oil group
Active Comparator group
Description:
Treatment Group.
Treatment:
Dietary Supplement: EPAX 6000 EE 1000mg (0.6 gr DHA+EPA)
Control group
Placebo Comparator group
Description:
Placebo group
Treatment:
Dietary Supplement: Capsules (Placebo)

Trial contacts and locations

1

Loading...

Central trial contact

Pierre Singer, Professor, MD; Milana Grinev, RN, Study Coordinator

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems